Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study.
Dorman SE, Schumacher SG, Alland D, Nabeta P, Armstrong DT, King B, Hall SL, Chakravorty S, Cirillo DM, Tukvadze N, Bablishvili N, Stevens W, Scott L, Rodrigues C, Kazi MI, Joloba M, Nakiyingi L, Nicol MP, Ghebrekristos Y, Anyango I, Murithi W, Dietze R, Lyrio Peres R, Skrahina A, Auchynka V, Chopra KK, Hanif M, Liu X, Yuan X, Boehme CC, Ellner JJ, Denkinger CM; study team. Dorman SE, et al. Among authors: ghebrekristos y. Lancet Infect Dis. 2018 Jan;18(1):76-84. doi: 10.1016/S1473-3099(17)30691-6. Epub 2017 Nov 30. Lancet Infect Dis. 2018. PMID: 29198911 Free PMC article.
Frequent Suboptimal Thermocycler Ramp Rate Usage Negatively Impacts GenoType MTBDRsl VER 2.0 Performance for Second-Line Drug-Resistant Tuberculosis Diagnosis.
Derendinger B, de Vos M, Pillay S, Venter R, Metcalfe J, Ghebrekristos Y, Minnies S, Dolby T, Beylis N, Warren R, Theron G. Derendinger B, et al. Among authors: ghebrekristos y. J Mol Diagn. 2022 May;24(5):494-502. doi: 10.1016/j.jmoldx.2022.01.003. Epub 2022 Jan 31. J Mol Diagn. 2022. PMID: 35108607 Free PMC article.
Management of false-positive rifampicin resistant Xpert MTB/RIF.
Beylis N, Ghebrekristos Y, Nicol M. Beylis N, et al. Among authors: ghebrekristos y. Lancet Microbe. 2020 Oct;1(6):e238. doi: 10.1016/S2666-5247(20)30123-3. Epub 2020 Oct 7. Lancet Microbe. 2020. PMID: 35544218 Free article. No abstract available.
Xpert MTB/RIF Ultra on contaminated liquid cultures for tuberculosis and rifampicin-resistance detection: a diagnostic accuracy evaluation.
Ghebrekristos YT, Beylis N, Centner CM, Venter R, Derendinger B, Tshivhula H, Naidoo S, Alberts R, Prins B, Tokota A, Dolby T, Marx F, Omar SV, Warren R, Theron G. Ghebrekristos YT, et al. Lancet Microbe. 2023 Oct;4(10):e822-e829. doi: 10.1016/S2666-5247(23)00169-6. Epub 2023 Sep 19. Lancet Microbe. 2023. PMID: 37739001 Free PMC article.
Expanding Xpert MTB/RIF Ultra® and LF-LAM testing for diagnosis of tuberculosis among HIV-positive adults admitted to hospitals in Tanzania and Mozambique: a randomized controlled trial (the EXULTANT trial).
Mangu C, Cossa M, Ndege R, Khosa C, Leukes V, de la Torre-Pérez L, Machiana A, Kivuma B, Mnzava D, Zachariah C, Manjate P, Tagliani E, Schacht C, Buech J, Singh S, Ehrlich J, Riess F, Sanz S, Kranzer K, Cox H, Sabi I, Nguenha D, Meggi B, Weisser M, Ntinginya N, Schumacher S, Ruhwald M, Penn-Nicholson A, Garcia-Basteiro AL; TB-CAPT Consortium. Mangu C, et al. BMC Infect Dis. 2024 Aug 15;24(1):831. doi: 10.1186/s12879-024-09651-z. BMC Infect Dis. 2024. PMID: 39148008 Free PMC article. Clinical Trial.
22 results